» Articles » PMID: 40066215

Why Is Social Reintegration Support for Patients With Left Ventricular Assist Device Necessary?

Overview
Journal Circ Rep
Date 2025 Mar 11
PMID 40066215
Authors
Affiliations
Soon will be listed here.
Abstract

Left ventricular assist devices (LVADs) serve as critical life-sustaining therapy for patients with end-stage heart failure awaiting heart transplantation, significantly improving survival rates and enabling social reintegration. However, many patients with LVAD face multiple challenges in their daily lives and social reintegration, such as anxiety about the device, low societal awareness, and economic and psychological burdens. In Japan, where prolonged waiting periods for heart transplants are inevitable, these challenges further exacerbate the economic and psychological burdens on both patients and caregivers. We present the case of a patient with an LVAD who expressed the desire to return to employment after receiving psychological counseling, and discuss the specific outcomes and challenges of employment support. A multidisciplinary team, including physicians, psychologists, and employment specialists, developed an individualized support plan. This led to successful steps toward social reintegration, which was accomplished in collaboration with the workplace. This case highlights the importance of early intervention during the heart transplant waiting period, specifically the LVAD implantation period, along with continuous psychological, economic, and employment support to improve quality of life post-transplant. Establishing a coordinated support system that involves healthcare providers, employers, and local communities is crucial for the successful social reintegration of patients with an LVAD. Specific measures, such as regular mental health counseling and flexible employment arrangements, are essential to achieving this goal.

References
1.
Tress F, Spitz-Koeberich C, Rebafka A, Schibilsky D, Kugler C . Balancing normalcy and safety: health-related needs in patients with a ventricular assist device within their home environment. Eur J Cardiovasc Nurs. 2021; 21(5):446-452. DOI: 10.1093/eurjcn/zvab113. View

2.
Clerkin K, Garan A, Wayda B, Givens R, Yuzefpolskaya M, Nakagawa S . Impact of Socioeconomic Status on Patients Supported With a Left Ventricular Assist Device: An Analysis of the UNOS Database (United Network for Organ Sharing). Circ Heart Fail. 2016; 9(10). PMC: 5123683. DOI: 10.1161/CIRCHEARTFAILURE.116.003215. View

3.
Kormos R, Antonides C, Goldstein D, Cowger J, Starling R, Kirklin J . Updated definitions of adverse events for trials and registries of mechanical circulatory support: A consensus statement of the mechanical circulatory support academic research consortium. J Heart Lung Transplant. 2020; 39(8):735-750. DOI: 10.1016/j.healun.2020.03.010. View

4.
Kato N, Okada I, Kagami Y, Endo M, Hatano M, Ono M . Quality of life of family caregivers of patients with a left ventricular assist device in Japan. J Cardiol. 2017; 71(1):81-87. DOI: 10.1016/j.jjcc.2017.06.004. View

5.
Saito S, Yoshioka D, Kawamura T, Kawamura A, Misumi Y, Akazawa Y . The foremost and greatest barrier to end-stage heart failure treatment: the impact of caregiver shortage. J Artif Organs. 2024; . DOI: 10.1007/s10047-024-01463-x. View